Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Inflammatory Bowel Disease Clinical Trials
Inflammatory Bowel Disease clinical trials are recruiting across 166 cities. Here are the cities with the most active studies:
Inflammatory Bowel Disease Trial Phases
52 research organizations are sponsoring inflammatory bowel disease trials.
About Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) encompasses chronic inflammatory conditions of the gastrointestinal tract, primarily Crohn's disease and ulcerative colitis. It affects millions worldwide and can cause debilitating symptoms. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.
Clinical trials are advancing new treatments for inflammatory bowel disease. Currently, 100 studies are recruiting a combined 46,714 participants across the United States. Research is being conducted by 52 organizations including Seattle Children's Hospital, University of Pittsburgh, AbbVie and 49 others.
2026 Inflammatory Bowel Disease Research Landscape
As of September 2026, the inflammatory bowel disease clinical trial landscape includes 100 actively recruiting studies across 166 cities in the United States. These studies are collectively seeking 46,714 participants, with an average enrollment target of 467 per study.
The research spans multiple phases of development: 29 studies are in PHASE3, 28 studies are in PHASE2, 18 studies are in NA, 8 studies are in PHASE4, 1 study is in PHASE1. The presence of Phase 3 trials indicates that some inflammatory bowel disease treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 52 different organizations, including Seattle Children's Hospital, University of Pittsburgh, AbbVie, University of California, San Francisco, Eli Lilly and Company, and 47 others. The large number of sponsors reflects significant research interest and investment in inflammatory bowel disease treatment advancement.
Geographically, inflammatory bowel disease trials are most concentrated in New York, New York (23 trials); Los Angeles, California (21 trials); Miami, Florida (17 trials); Lancaster, California (16 trials); Kissimmee, Florida (16 trials) and 7 other cities.
Featured Inflammatory Bowel Disease Studies
Highlighted recruiting studies for inflammatory bowel disease, selected by enrollment size and research scope.
Familial Inflammatory Bowel Disease Early Risk
Brief Summary The aim of the FIBER study is to identify potential triggers associated with the later development of IBD (inflammatory bowel disease) based on baseline characteristics and biosamples (blood, urine, stool, saliva, and tissue). Aim 1: To identify clinical, demographic, and immunologic factors associated with an increased risk of developing IBD in family members of IBD patients. Thi...
Inflammatory Bowel Disease (IBD) Research Registry
Patients seen at the Center for Inflammatory Bowel Disease will be asked to provide their written informed consent (authorization) to allow their identifiable medical record information related to their Inflammatory Bowel Disease to be placed in Center's Research Registry for the purpose of facilitating retrospective research studies directed at Inflammatory Bowel Disease, and the identification a...
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) in the digestive tract. CD can affect any part of the digestive tract causing many different symptoms including belly pain, diarrhea, tiredness, and weight loss. UC affects the lining of the rectum and colon (large intestine) and can cause bl...
Frequently Asked Questions About Inflammatory Bowel Disease Clinical Trials
Are there inflammatory bowel disease clinical trials near me?
Yes, there are 100 inflammatory bowel disease clinical trials currently recruiting across 166+ cities in the United States, including New York, New York; Los Angeles, California; Miami, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a inflammatory bowel disease clinical trial?
To join a inflammatory bowel disease clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are inflammatory bowel disease clinical trials free?
Yes, participation in inflammatory bowel disease clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of inflammatory bowel disease treatments are being studied?
Current inflammatory bowel disease clinical trials are testing a range of approaches across PHASE3 (29 studies), PHASE2 (28 studies), NA (18 studies), PHASE4 (8 studies), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 52 research organizations.
Is it safe to participate in inflammatory bowel disease clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated September 1, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated September 1, 2026 · Data from ClinicalTrials.gov